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Disseminated neonatal herpes simplex virus (HSV)
infection is characterized by progressive multiple organ fail-
ure and high mortality rates. It can result from infection with
either HSV-1 or HSV-2. We report a case of disseminated
neonatal herpes that was caused by HSV-1 and HSV-2.
N
eonatal herpes simplex virus (HSV) infection is
among the most severe perinatal infections. Most
(85%) neonatal HSV infections are acquired during deliv-
ery, although in utero (5%) and postnatal (10%) infections
do occur (1). The risk for transmission to the newborn is
much higher in women with primary HSV infections (2).
Neonatal herpes can be localized to skin, eyes, and mouth
(≈45% of cases), involve the central nervous system
(≈30% of cases), or can cause disseminated infection
involving multiple organs such as liver, lungs, adrenal
glands, and brain (≈25% of cases). 
Disseminated infection is the most severe form of
neonatal herpes, with a mortality rate of 85% for untreated
neonates (3). It is usually observed when the infant is 5–9
days old; signs include irritability, seizures, respiratory dis-
tress, jaundice, bleeding diatheses, shock, and often vesic-
ular exanthema (3,4). Early treatment with high-dose
acyclovir reduces the mortality rate (5). Early recognition
of disseminated infection is difficult because of nonspecif-
ic symptoms and signs of sepsis and because initiation of
antiviral therapy is often delayed (1). The high risk for
death requires prompt diagnostic evaluation that includes
testing by HSV DNAPCR as the preferred method or virus
culture (6,7).
Neonatal herpes can result from infection with either
HSV-1 or HSV-2; the latter is associated with a poorer
prognosis (7). We report a case of disseminated neonatal
herpes infection with HSV-1 and HSV-2.
The Case
A full-term infant girl had febrile illness and lethargy
and fed poorly at 3 days of age. She was born by normal
vaginal delivery with prolonged expulsion of placental
membranes. Initial laboratory investigations showed a nor-
mal leukocyte count (11,100 cells/µL), a slightly elevated
C-reactive protein level (18 mg/L), and elevated levels of
liver enzymes (aspartate aminotransferase [AST] 283 U/L
and alanine aminotransferase [ALT] 111 U/L). Ascreen for
sepsis was performed and she was treated with broad-spec-
trum antimicrobial drugs. On day 4 of life, signs of respi-
ratory distress appeared and intermittent mechanical
ventilation was initiated. A chest radiograph showed
streaky and patchy bilateral pulmonary opacities and right-
side pleural effusion. Neurologic examination showed
mild hypotonia. On day 6 of life, she was still febrile with
thrombocytopenia (56,000 cells/µL), an increased C-reac-
tive protein level (32 mg/L), and signs of fulminate liver
failure (AST 13,740 U/L and ALT 3,180 U/L) and marked
coagulopathy. Despite full intensive care support, she died
of rapidly progressive multiple organ failure on day 9.
Postmortem findings showed widespread necrosis of
lungs, liver, and adrenal glands. Serologic investigations
showed no immunoglobulin M (IgM) and IgG antibodies
for HSV-1 and HSV-2. An ELISA (Virion/Serion,
Würzburg, Germany) detected IgG antibodies for rubella
virus, cytomegalovirus, varicella zoster virus, parainfluen-
za virus, adenovirus, and coxsackie B virus; however,
these results were not indicative of active infection. Blood
and urine bacterial cultures were negative. Retrospective
virologic examination of postmortem specimens (tracheal
aspirate, liver, lungs, and stomach) in different cell lines
(Vero, RD, L20B) showed cytopathogenic virus, which
was suggestive of HSV that was identified by PCR. 
Viral DNA was extracted from all postmortem speci-
mens (tracheal aspirate, liver, lungs, and gut) and all virus-
positive cultures of tracheal aspirate, liver, lungs, and
stomach in different cell cultures (Vero, RD, L20B) by
using the QIAamp DNA Mini Kit (Qiagen, Valencia, CA,
USA). The DNAwas then used for HSVDNAPCR. Target
DNAwas amplified with primers for the HSV-1 thymidine
kinase gene (Fw 5′-AGCGTCTTGTCATTGGCGAA-3′
and Rev 5′-TTTTCTGCTCCAGGCGGACT-3′) and for
the HSV-2 DNA polymerase gene (Fw 5′-CGTCCTG
GAGTTTGACAGCG-3′ and Rev 5′-CAGCAGC
GAGTCCTGCACACAA-3′) (8). A342-bp band for HSV-
1 and a 445-bp band for HSV-2 were found in all post-
mortem specimens (Figure) and in all virus-positive
cultures examined.
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the ABI Prism BigDye 3.1 sequencing system (Applied
Biosystems, Foster City, CA, USA) and showed identical
sequences in different specimens. When these sequences
were compared with those available in the GenBank data-
base by using the BLAST tool (www.ncbi.nlm.nih.gov/
BLAST/), the highest similarity was observed for relevant
HSV genes, namely HSV-1 strain CL 101 and HSV-2
strain KN 53690.
Retrospective serologic examination of maternal sam-
ples and avidity tests at 3 different time points detected
IgM and IgG antibodies initially for HSV-1 and subse-
quently for HSV-2 (Table); the increase in IgG avidity to
both virus types correlated with primary infection.
Conclusions
Neonatal disseminated HSV infection is most fre-
quently caused by HSV-2, although HSV-1 can also be the
cause. To the best of our knowledge, our patient is the first
PCR-confirmed case of disseminated neonatal herpes
caused by concomitant infection with HSV-1 and HSV-2.
Prompt diagnosis was difficult because of the early
appearance of nonspecific symptoms (day 3), signs of res-
piratory distress (day 4), and rapid development of multi-
ple organ failure (day 6). Oral and skin vesicular lesions
were not detected, and the mother had no history of herpes
infection. Serologic HSV status of the newborn was not of
great clinical value. Postmortem virologic examination
including viral isolation and HSV DNA PCR identified
HSV-1 and HSV-2. 
The results of retrospective serologic examination for
maternal IgM and IgG antibodies to HSV-1 and HSV-2 and
avidity tests suggested that primary maternal HSV infec-
tion occurred near the time of delivery. Because of the 2-
month delay in obtaining maternal serologic results,
whether the mother was infected by both HSV types con-
comitantly or successively near the time of delivery is
unclear. These results suggest that the newborn acquired
the infection during delivery, although in utero infection
cannot be ruled out. The rapid onset of disseminated
neonatal HSV infection (day 3) and development of multi-
ple organ failure seen in this patient may be the result of
concomitant infection with HSV-1 and HSV-2.
Acknowledgments
We thank Slavisa Djurisic for providing samples and
Radmila Znidarcic and Gabrijela Pavlovic for excellent technical
assistance.
This study was supported by Ministry of Science,
Technology and Development, Republic of Serbia, grant 145047.
Dr Knezevic is a medical microbiologist and assistant pro-
fessor of microbiology and immunology at the Institute of
Microbiology and Immunology, School of Medicine, University
of Belgrade. Her research interests include persistent viral infec-
tions, in particular herpesvirus and human papillomavirus
infections.
References
1.  Fidler KJ, Pierce CM, Cubitt WD, Novelli V, Peters MJ. Could
neonatal disseminated herpes simplex virus infections be treated
earlier? J Infect. 2004;49:141–6.
2.  Whitley R. Neonatal herpes simplex virus infection. Curr Opin
Infect Dis. 2004;17:243–6.
3.  Kimberlin D. Herpes simplex virus, meningitis and encephalitis in
neonates. Herpes. 2004;11:65A–76A.
4.  Whitley R, Arvin A, Prober C, Corey L, Burchett S, Plotkin S, et al.
The National Institute of Allergy and Infectious Diseases
Collaborative Antiviral Study Group. Predictors of morbidity and
mortality in neonates with herpes simplex virus infections. N Engl
J Med. 1991;324:450–545.
Herpes Simplex Virus Infection
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 2, February 2007 303
Figure. Results of herpes simplex virus (HSV) type 1 and type 2
PCRs in postmortem specimens. Lane 1, 100-bp DNAladder; lane
2, negative control HSV-1; lane 3, positive control HSV-1; lane 4,
tracheal aspirate HSV-1; lane 5, liver HSV-1; lane 6, lung HSV-1;
lane 7, stomach HSV-1; lane 8, negative control HSV-2; lane 9,
positive control HSV-2; lane 10, tracheal aspirate HSV-2; lane 11,
liver HSV-2; lane 12, lung HSV-2; lane 13, stomach HSV-2. 5. Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Corey L, Gruber
WC, et al. The National Institute of Allergy and Infectious Diseases
Collaborative Antiviral Study Group. Safety and efficacy of high-
dose intravenous acyclovir in the management of neonatal herpes
simplex virus infections. Pediatrics. 2001;108:230–8.
6.  Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Frenkel LM,
Gruber WC, et al. The National Institute of Allergy and Infectious
Diseases Collaborative Antiviral Study Group. Natural history of
neonatal herpes simplex virus infections in the acyclovir era.
Pediatrics. 2001;108:223–9.
7.  Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol
Rev. 2004;17:1–13.
8.  Bai X, Rogers BB, Harkins PC, Sommerauer J, Squires R, Rotondo
K, et al. Predictive value of quantitative PCR-based viral burden
analysis for eight human herpesviruses in pediatric solid organ
transplant patients. J Mol Diagn. 2000;2:191–201.
Address for correspondence: Aleksandra Knezevic, Institute of
Microbiology and Immunology, School of Medicine, University of
Belgrade, Dr Subotica 1/1, 11000 Belgrade, Serbia; email:
aknezevic@med.bg.ac.yu
DISPATCHES
304 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 2, February 2007
Search
past issues